Skip to main content
Top
Published in: Internal and Emergency Medicine 5/2022

20-05-2022 | SARS-CoV-2 | IM - ORIGINAL

Independent predictors of in-hospital mortality and the need for intensive care in hospitalized non-critical COVID-19 patients: a prospective cohort study

Authors: Nursel Çalık Başaran, Murat Özdede, Oğuz Abdullah Uyaroğlu, Taha Koray Şahin, Berşan Özcan, Hakan Oral, Lale Özışık, Gülay Sain Güven, Mine Durusu Tanrıöver

Published in: Internal and Emergency Medicine | Issue 5/2022

Login to get access

Abstract

One of the most helpful strategies to deal with ongoing coronavirus pandemics is to use some prudence when treating patients infected with SARS-CoV-2. We aimed to evaluate the clinical, demographic, and laboratory parameters that might have predictive value for in-hospital mortality and the need for intensive care and build a model based on them. This study was a prospective, observational, single-center study including non-critical patients admitted to COVID-19 wards. Besides classical clinic-demographic features, basic laboratory parameters obtained on admission were tested, and then new models for each outcome were developed built on the most significant variables. Receiver operating characteristics (ROC) analyses were performed by calculating each model’s probability. A total of 368 non-critical hospitalized patients were recruited, the need for ICU care was observed in 70 patients (19%). The total number of patients who died in either ICU or wards was 39 (10.6%). The first two models (based on clinical features and demographics) were developed to predict ICU and death, respectively; older age, male sex, active cancer, and low baseline saturation were noted to be independent predictors. The area under the curve values of the first two models were noted 0.878 and 0.882 (p < .001; confidence interval [CI] 95% [0.837–0.919], p < .001; CI 95% [0.844–0.922]). Following two models, the third and fourth were based on laboratory parameters with clinic-demographic features. Initial lower sodium and lower albumin levels were determined as independent factors in predicting the need for ICU care; higher blood urea nitrogen and lower albumin were independent factors in predicting in-hospital mortality. The area under the curve values of the third and fourth model was noted 0.938 and 0.929, respectively (p < .001; CI 95% [0.912–0.965], p < .001; CI 95% [0.895–962]). By integrating the widely available blood tests results with simple clinic demographic data, non-critical patients can be stratified according to their risk level. Such stratification is essential to filter the patients’ non-critical underlying diseases and conditions that can obfuscate the physician’s predictive capacity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Cheng S, Wu D, Li J et al (2020) Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study. Respir Res 21(1):277CrossRef Cheng S, Wu D, Li J et al (2020) Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study. Respir Res 21(1):277CrossRef
2.
go back to reference Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506CrossRef Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497–506CrossRef
3.
go back to reference Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069CrossRef Wang D, Hu B, Hu C et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323(11):1061–1069CrossRef
4.
go back to reference Macedo A, Gonçalves N, Febra C (2021) COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemiol 57:14–21CrossRef Macedo A, Gonçalves N, Febra C (2021) COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis. Ann Epidemiol 57:14–21CrossRef
5.
go back to reference Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395(10223):470–473CrossRef Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395(10223):470–473CrossRef
6.
go back to reference Li LQ, Huang T, Wang YQ et al (2020) COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 92(6):577–583CrossRef Li LQ, Huang T, Wang YQ et al (2020) COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol 92(6):577–583CrossRef
7.
go back to reference Weiss P, Murdoch DR (2020) Clinical course and mortality risk of severe COVID-19. Lancet 395(10229):1014–1015CrossRef Weiss P, Murdoch DR (2020) Clinical course and mortality risk of severe COVID-19. Lancet 395(10229):1014–1015CrossRef
8.
go back to reference Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062CrossRef Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062CrossRef
9.
go back to reference Hadjadj J, Yatim N, Barnabei L et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science (New York, NY) 369(6504):718–724CrossRef Hadjadj J, Yatim N, Barnabei L et al (2020) Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science (New York, NY) 369(6504):718–724CrossRef
10.
go back to reference Han H, Ma Q, Li C et al (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9(1):1123–1130CrossRef Han H, Ma Q, Li C et al (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9(1):1123–1130CrossRef
11.
go back to reference Heller RA, Sun Q, Hackler J et al (2021) Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker. Redox Biol 38:101764CrossRef Heller RA, Sun Q, Hackler J et al (2021) Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker. Redox Biol 38:101764CrossRef
12.
go back to reference Cummings BC, Ansari S, Motyka JR et al (2021) Predicting intensive care transfers and other unforeseen events: analytic model validation study and comparison to existing methods. JMIR Med Inform 9(4):e25066CrossRef Cummings BC, Ansari S, Motyka JR et al (2021) Predicting intensive care transfers and other unforeseen events: analytic model validation study and comparison to existing methods. JMIR Med Inform 9(4):e25066CrossRef
15.
go back to reference Cheng A, Hu L, Wang Y et al (2020) Diagnostic performance of initial blood urea nitrogen combined with d-dimer levels for predicting in-hospital mortality in COVID-19 patients. Int J Antimicrob Agents 56(3):106110CrossRef Cheng A, Hu L, Wang Y et al (2020) Diagnostic performance of initial blood urea nitrogen combined with d-dimer levels for predicting in-hospital mortality in COVID-19 patients. Int J Antimicrob Agents 56(3):106110CrossRef
16.
go back to reference Yao Z, Zheng X, Zheng Z et al (2021) Construction and validation of a machine learning-based nomogram: a tool to predict the risk of getting severe coronavirus disease 2019 (COVID-19). Immun Inflamm Dis 9(2):595–607CrossRef Yao Z, Zheng X, Zheng Z et al (2021) Construction and validation of a machine learning-based nomogram: a tool to predict the risk of getting severe coronavirus disease 2019 (COVID-19). Immun Inflamm Dis 9(2):595–607CrossRef
19.
go back to reference Velavan TP, Meyer CG (2020) Mild versus severe COVID-19: laboratory markers. Int J Infect Dis 95:304–307CrossRef Velavan TP, Meyer CG (2020) Mild versus severe COVID-19: laboratory markers. Int J Infect Dis 95:304–307CrossRef
20.
go back to reference Xie J, Wang Q, Xu Y et al (2021) Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis. Ann Palliat Med 10(2):1928–1949CrossRef Xie J, Wang Q, Xu Y et al (2021) Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis. Ann Palliat Med 10(2):1928–1949CrossRef
21.
go back to reference Knight SR, Ho A, Pius R et al (2020) Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ (Clinical research ed) 370:m3339 Knight SR, Ho A, Pius R et al (2020) Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ (Clinical research ed) 370:m3339
22.
go back to reference Rodriguez-Nava G, Yanez-Bello MA, Trelles-Garcia DP et al (2021) Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting. Int J Infect Dis 102:571–576CrossRef Rodriguez-Nava G, Yanez-Bello MA, Trelles-Garcia DP et al (2021) Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting. Int J Infect Dis 102:571–576CrossRef
23.
go back to reference Volff M, Tonon D, Bourenne J et al (2020) No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients. Anaesth Crit Care Pain Med 39(5):577–578CrossRef Volff M, Tonon D, Bourenne J et al (2020) No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients. Anaesth Crit Care Pain Med 39(5):577–578CrossRef
24.
go back to reference Cheng F-Y, Joshi H, Tandon P et al (2020) Using machine learning to predict ICU transfer in hospitalized COVID-19 patients. J Clin Med 9(6):1668CrossRef Cheng F-Y, Joshi H, Tandon P et al (2020) Using machine learning to predict ICU transfer in hospitalized COVID-19 patients. J Clin Med 9(6):1668CrossRef
25.
go back to reference Puah SH, Young BE, Chia PY et al (2021) Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore. Sci Rep 11(1):7477CrossRef Puah SH, Young BE, Chia PY et al (2021) Clinical features and predictors of severity in COVID-19 patients with critical illness in Singapore. Sci Rep 11(1):7477CrossRef
26.
go back to reference Lang M, Som A, Mendoza DP et al (2020) Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis 20(12):1365–1366CrossRef Lang M, Som A, Mendoza DP et al (2020) Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis 20(12):1365–1366CrossRef
28.
go back to reference Busana M, Giosa L, Cressoni M et al (2021) The impact of ventilation–perfusion inequality in COVID-19: a computational model. J Appl Physiol 130(3):865–876CrossRef Busana M, Giosa L, Cressoni M et al (2021) The impact of ventilation–perfusion inequality in COVID-19: a computational model. J Appl Physiol 130(3):865–876CrossRef
29.
go back to reference Bavishi C, Bonow RO, Trivedi V et al (2020) Special article—acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Prog Cardiovasc Dis 63(5):682–689CrossRef Bavishi C, Bonow RO, Trivedi V et al (2020) Special article—acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Prog Cardiovasc Dis 63(5):682–689CrossRef
30.
go back to reference Hu H, Ma F, Wei X, Fang Y (2021) Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J 42(2):206CrossRef Hu H, Ma F, Wei X, Fang Y (2021) Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J 42(2):206CrossRef
31.
go back to reference Hui H, Zhang Y, Yang X et al (2020) Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. MedRxiv. 5:372 Hui H, Zhang Y, Yang X et al (2020) Clinical and radiographic features of cardiac injury in patients with 2019 novel coronavirus pneumonia. MedRxiv. 5:372
32.
go back to reference Li T, Zhang Y, Gong C et al (2020) Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr 74(6):871–875CrossRef Li T, Zhang Y, Gong C et al (2020) Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr 74(6):871–875CrossRef
33.
go back to reference Soeters PB, Wolfe RR, Shenkin A (2019) Hypoalbuminemia: pathogenesis and clinical significance. J Parenter Enter Nutr 43(2):181–193CrossRef Soeters PB, Wolfe RR, Shenkin A (2019) Hypoalbuminemia: pathogenesis and clinical significance. J Parenter Enter Nutr 43(2):181–193CrossRef
34.
go back to reference de la Rica R, Borges M, Aranda M et al (2020) Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study. Microorganisms 8(8):1106CrossRef de la Rica R, Borges M, Aranda M et al (2020) Low albumin levels are associated with poorer outcomes in a case series of COVID-19 patients in Spain: a retrospective cohort study. Microorganisms 8(8):1106CrossRef
36.
go back to reference Aziz M, Fatima R, Lee-Smith W, Assaly R (2020) The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Critical care (London, England) 24(1):255CrossRef Aziz M, Fatima R, Lee-Smith W, Assaly R (2020) The association of low serum albumin level with severe COVID-19: a systematic review and meta-analysis. Critical care (London, England) 24(1):255CrossRef
37.
go back to reference Huang J, Cheng A, Kumar R et al (2020) Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol 92(10):2152–2158CrossRef Huang J, Cheng A, Kumar R et al (2020) Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity. J Med Virol 92(10):2152–2158CrossRef
38.
go back to reference Gao S, Jiang F, Jin W et al (2020) Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China. Aging (Albany NY) 12(13):12504–12516CrossRef Gao S, Jiang F, Jin W et al (2020) Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China. Aging (Albany NY) 12(13):12504–12516CrossRef
39.
go back to reference Li Z, Wu M, Yao J et al (2020) Caution on kidney dysfunctions of COVID-19 patients. medRxiv. 12:48 Li Z, Wu M, Yao J et al (2020) Caution on kidney dysfunctions of COVID-19 patients. medRxiv. 12:48
40.
go back to reference Cheng Y, Luo R, Wang K et al (2020) Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv. 69:752 Cheng Y, Luo R, Wang K et al (2020) Kidney impairment is associated with in-hospital death of COVID-19 patients. medRxiv. 69:752
41.
go back to reference Liu Q, Wang Y, Zhao X et al (2021) Diagnostic performance of a blood urea nitrogen to creatinine ratio-based nomogram for predicting in-hospital mortality in COVID-19 patients. Risk Manag Healthc Policy 14:117–128CrossRef Liu Q, Wang Y, Zhao X et al (2021) Diagnostic performance of a blood urea nitrogen to creatinine ratio-based nomogram for predicting in-hospital mortality in COVID-19 patients. Risk Manag Healthc Policy 14:117–128CrossRef
Metadata
Title
Independent predictors of in-hospital mortality and the need for intensive care in hospitalized non-critical COVID-19 patients: a prospective cohort study
Authors
Nursel Çalık Başaran
Murat Özdede
Oğuz Abdullah Uyaroğlu
Taha Koray Şahin
Berşan Özcan
Hakan Oral
Lale Özışık
Gülay Sain Güven
Mine Durusu Tanrıöver
Publication date
20-05-2022
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 5/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-02962-6

Other articles of this Issue 5/2022

Internal and Emergency Medicine 5/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.